6-Jul-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
About F1000
What is F1000 Biology?
Key features
How it's organized
FAQs
Faculties and sections
Scope of sections
List of Faculty Members
The evaluation system
Citing F1000
Take a tour of the site
Accessing fulltexts
PubMed linkout
How to subscribe
Academic subscriptions
Corporate subscriptions
Try F1000 for free
Who we are
Media information
Librarian resources
Press releases
In the press
Developing countries
F1000 Medicine
Terms and conditions
Privacy policy
Contact us
Mark Anderson
UCSF Diabetes Center, United States of America
Faculty Member: IMMUNOLOGY > Autoimmunity [ since 16 November 2006 ]
[
Evaluations
]
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Evaluations
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M, Björklund P, …, Holländer GA, Kämpe O
N Engl J Med
2008 Mar 6
358
(10):1018-28 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Kenneth Tung / Mark Anderson
Evaluated 23 Apr 2008
Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism.
Derbinski J, Pinto S, …, Hexel K, Kyewski B
Proc Natl Acad Sci U S A
2008 Jan 15
105
(2):657-62 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Torben Lund / Mark Anderson
Evaluated 7 Feb 2008
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Wenzlau JM, Juhl K, …, Davidson HW, Hutton JC
Proc Natl Acad Sci U S A
2007 Oct 23
104
(43):17040-5 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Ivan Gerling / Mark Anderson / Peter Van Endert
Evaluated 12 Nov 2007
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus.
Giraud M, Taubert R, …, Kyewski B, Garchon HJ
Nature
2007 Aug 23
448
(7156):934-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Mark Anderson
Evaluated 31 Aug 2007
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.
van Heel DA, Franke L, …, Deloukas P, Wijmenga C
Nat Genet
2007 Jul
39
(7):827-9 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Mark Anderson
Evaluated 5 Jul 2007
RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla.
Rossi SW, Kim MY, …, Lane PJ, Anderson G
J Exp Med
2007 Jun 11
204
(6):1267-72 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Mark Anderson / Antony Basten
Evaluated 22 May 2007
NALP1 in vitiligo-associated multiple autoimmune disease.
Jin Y, Mailloux CM, …, Fain PR, Spritz RA
N Engl J Med
2007 Mar 22
356
(12):1216-25 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Mark Anderson / Siamak Bahram / Giulio Superti-Furga
Evaluated 12 Apr 2007
Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
Marson A, Kretschmer K, …, von Boehmer H, Young RA
Nature
2007 Feb 22
445
(7130):931-5 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jin-Xiong She / Mark Anderson / Thomas Graf
Evaluated 6 Mar 2007
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
Kim JM, Rasmussen JP, Rudensky AY
Nat Immunol
2007 Feb
8
(2):191-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Mark Anderson / Paul Gleeson
Evaluated 19 Dec 2006
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Duerr RH, Taylor KD, …, Nicolae DL, Cho JH
Science
2006 Dec 1
314
(5804):1461-3 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Mark Anderson / Paul Lyons
Evaluated 19 Dec 2006
^Top
Back to Faculty Members
© 1999-2008 Biology Reports Ltd unless otherwise stated
< info@f1000.com >
Terms and conditions
Legal info